Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Short-Term Debt issuancesShort-Term Debt repayments
Ratios

Myriad Genetics (MYGN) Shares Issued (2016 - 2024)

Historic Shares Issued for Myriad Genetics (MYGN) over the last 16 years, with Q4 2024 value amounting to $2.9 million.

  • Myriad Genetics' Shares Issued fell 9753.4% to $2.9 million in Q4 2024 from the same period last year, while for Sep 2025 it was $120.5 million, marking a year-over-year increase of 246.6%. This contributed to the annual value of $5.9 million for FY2024, which is 9498.3% down from last year.
  • As of Q4 2024, Myriad Genetics' Shares Issued stood at $2.9 million, which was down 9753.4% from $117.6 million recorded in Q4 2023.
  • In the past 5 years, Myriad Genetics' Shares Issued registered a high of $117.6 million during Q4 2023, and its lowest value of $300000.0 during Q1 2020.
  • Over the past 5 years, Myriad Genetics' median Shares Issued value was $2.3 million (recorded in 2020), while the average stood at $16.1 million.
  • Its Shares Issued has fluctuated over the past 5 years, first soared by 873333.33% in 2021, then plummeted by 9886.79% in 2022.
  • Quarter analysis of 5 years shows Myriad Genetics' Shares Issued stood at $1.8 million in 2020, then changed by 0.0% to $1.8 million in 2021, then soared by 33.33% to $2.4 million in 2022, then skyrocketed by 4800.0% to $117.6 million in 2023, then tumbled by 97.53% to $2.9 million in 2024.
  • Its Shares Issued stands at $2.9 million for Q4 2024, versus $117.6 million for Q4 2023 and $2.4 million for Q4 2022.